Loading...

Henry Vanbrocklin, PhD

Title(s)Professor, Radiology
SchoolSchool of Medicine
Address185 Berry Street Bldg B
San Francisco CA 94158
Phone415-353-4569
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Molecular Imaging 2011Editor-in-Chief
    Society of Nuclear Medicine2006SNM Presidents Distinguished Service Award
    US Department of Energy1990Alexander Hollaender Distinguished Postdoctoral Fellow
    Society of Nuclear Medicine2010SNM Presidents Distinguished Service Award

    Collapse Overview 
    Collapse Overview
    Henry VanBrocklin, PhD, is a Professor in Residence, Director of the Radiopharmaceutical Research Program in the Center for Molecular and Functional Imaging (CMFI) at the University of California, San Francisco China Basin, and he is a Joint Faculty Scientist at the Lawrence Berkeley National Laboratory. Dr. VanBrocklin obtained his PhD in Radiopharmaceutical Chemistry from Washington University, St. Louis in 1990, and he completed a two-year postdoctoral program at the University of Illinois, Urbana in 1992. He maintains an active radiotracer research program in addition to providing tracers for collaborative basic science and translational clinical research. His research interests include short-lived radioisotope production to the creation of fluorine-18 and carcbon-11 labeling chemistry strategies for new radiotracer preparations and applications.

    Dr. VanBrocklin is one of the core faculty for the Master's in Biomedical Imaging (MSBI) program and a member of the MSBI executive committee.

    Dr. VanBrocklin was awarded the Alexander Hollaender Distinguished Postdoctoral Fellowship from the U.S. Department of Energy for developing positron-labeled estrogens, progestins, and androgens for tumor imaging. He has 70 published research articles.

    Expertise:
    Radiopharmaceutical

    Specialty:
    Short-lived radioisotope production to the creation of fluorine-18 and carbon-11 labeling chemistry strategies for new radiotracer preparations and applications, development of positron-labeled estrogens, progestin’s, androgens for tumor imaging

    Professional Interests:
    Developing radiopharmaceutical probes for PET and SPECT imaging applications including tracers for blood flow measurement, receptor-targeted tracers for prostate, pancreatic and breast cancer, and neurological imaging agents for neuroinflammation and excititory amino acid transport.

    Education and Training:
    • Doctor of Philosophy: Washington University, St. Louis - Radiopharmaceutical Chemistry
    • Postdoctoral Fellow: University of Illinois, Urbana

    Collapse Research 
    Collapse Research Activities and Funding
    Molecular Imaging of persistent HIV: CD30
    NIH R21AI152936Jan 12, 2021 - Dec 31, 2022
    Role: Principal Investigator
    In Vivo PET Imaging of HIV Infection
    NIH R01AI152932Aug 12, 2020 - Jul 31, 2025
    Role: Co-Principal Investigator
    Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based cancer imaging PET tracers on a single platform.
    NIH R43CA235909Sep 18, 2019 - Aug 31, 2020
    Role: Co-Principal Investigator
    Astroglial EAAT2 Changes in Live TBI Brain Determined by PET Imaging
    NIH R41NS105309Sep 1, 2018 - Dec 31, 2020
    Role: Principal Investigator
    Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology.
    NIH U01FD005517Sep 15, 2015 - Aug 31, 2021
    Role: Co-Principal Investigator
    Molecular Imaging of Chemical Threats and Countermeasures
    NIH U01NS092495Aug 1, 2015 - Jul 31, 2021
    Role: Co-Principal Investigator
    In vivo reporters of gene expression
    NIH R21AI114283Jul 15, 2014 - Jun 30, 2016
    Role: Co-Principal Investigator
    PET and MR-Compatible Bioreactor for Cross-Platform Biomarker Development
    NIH R21CA171766Aug 1, 2012 - Jul 31, 2015
    Role: Principal Investigator
    In Vivo Pharmacokinetic and Pharmacodynamic Dispositions of Positron Radiolabeled
    NIH R21NS072079Sep 30, 2010 - Aug 31, 2013
    Role: Co-Principal Investigator
    MicroPET/CT for Small Animal Imaging
    NIH S10RR023051Jun 1, 2007 - May 31, 2009
    Role: Principal Investigator
    Evaluation of Iodorotenone, A SPECT Perfusion Tracer
    NIH R01EB000482Mar 10, 2003 - Feb 29, 2008
    Role: Principal Investigator
    Targeted Molecular Probes for Tumor Imaging
    NIH R01CA094253Sep 5, 2002 - Aug 31, 2008
    Role: Principal Investigator
    DEVELOPMENT OF CANCER IMAGING AGENTS
    NIH R21CA079823Feb 1, 1999 - Jan 31, 2001
    Role: Principal Investigator
    MYOCARDIAL FLOW, FUNCTION AND METABOLISM BY PET AND MRI
    NIH P01HL025840Aug 1, 1980 - Aug 30, 2002
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Biological Distribution and Metabolic Profiles of Carbon-11 and Fluorine-18 Tracers of VX- and Sarin-Analogs in Sprague-Dawley Rats. Chem Res Toxicol. 2020 Dec 29. Hayes TR, Chao CK, Blecha JE, Huynh TL, Zinn KR, Thompson CM, Gerdes JM, VanBrocklin HF. PMID: 33373198.
      View in: PubMed   Mentions:    Fields:    
    2. An Analysis of Isoclonal Antibody Formats Suggests a Role for Measuring PD-L1 with Low Molecular Weight PET Radiotracers. Mol Imaging Biol. 2020 12; 22(6):1553-1561. PMID: 32813112.
      View in: PubMed   Mentions:    Fields:    
    3. Positron emission tomography evaluation of oxime countermeasures in live rats using the tracer O-(2-[18 F]fluoroethyl)-O-(p-nitrophenyl)methylphosphonate [18 F]-VXS. Ann N Y Acad Sci. 2020 11; 1479(1):180-195. Hayes TR, Blecha JE, Chao CK, Huynh TL, VanBrocklin HF, Zinn KR, Taylor PW, Gerdes JM, Thompson CM. PMID: 32436233.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    4. 124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma. J Nucl Med. 2021 Jan; 62(1):43-47. Aboian MS, Huang SY, Hernandez-Pampaloni M, Hawkins RA, VanBrocklin HF, Huh Y, Vo KT, Gustafson WC, Matthay KK, Seo Y. PMID: 32414950.
      View in: PubMed   Mentions: 2     Fields:    
    5. A Novel Radioligand Reveals Tissue Specific Pharmacological Modulation of Glucocorticoid Receptor Expression with Positron Emission Tomography. ACS Chem Biol. 2020 06 19; 15(6):1381-1391. Huang Y, Zhao N, Wang YH, Truillet C, Wei J, Blecha JE, VanBrocklin HF, Seo Y, Sayeed M, Feldman BJ, Aggarwal R, Behr SC, Shao H, Wilson DM, Villanueva-Meyer JE, Gestwicki JE, Evans MJ. PMID: 32255605.
      View in: PubMed   Mentions:    Fields:    
    6. Arabinofuranose-derived positron-emission tomography radiotracers for detection of pathogenic microorganisms. J Labelled Comp Radiopharm. 2020 May 15; 63(5):231-239. Kalita M, Parker MFL, Luu JM, Stewart MN, Blecha JE, VanBrocklin HF, Evans MJ, Flavell RR, Rosenberg OS, Ohliger MA, Wilson DM. PMID: 32222086.
      View in: PubMed   Mentions:    Fields:    
    7. PET/CT Imaging of Human TNFa Using [89Zr]Certolizumab Pegol in a Transgenic Preclinical Model of Rheumatoid Arthritis. Mol Imaging Biol. 2020 02; 22(1):105-114. Beckford-Vera DR, Gonzalez-Junca A, Janneck JS, Huynh TL, Blecha JE, Seo Y, Li X, VanBrocklin HF, Franc BL. PMID: 31065895.
      View in: PubMed   Mentions: 1     Fields:    
    8. High Enantiomeric Excess In-Loop Synthesis of d-[methyl-11C]Methionine for Use as a Diagnostic Positron Emission Tomography Radiotracer in Bacterial Infection. ACS Infect Dis. 2020 01 10; 6(1):43-49. Stewart MN, Parker MFL, Jivan S, Luu JM, Huynh TL, Schulte B, Seo Y, Blecha JE, Villanueva-Meyer JE, Flavell RR, VanBrocklin HF, Ohliger MA, Rosenberg O, Wilson DM. PMID: 31697062.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    9. PET Imaging of the EPR Effect in Tumor Xenografts Using Small 15 nm Diameter Polyethylene Glycols Labeled with Zirconium-89. . 2020 02; 19(2):673-679. Beckford Vera DR, Fontaine SD, VanBrocklin HF, Hearn BR, Reid R, Ashley GW, Santi DV. PMID: 31744896.
      View in: PubMed   Mentions:
    10. Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy. Mol Pharm. 2019 09 03; 16(9):3831-3841. Wang S, Blaha C, Santos R, Huynh T, Hayes TR, Beckford-Vera DR, Blecha JE, Hong AS, Fogarty M, Hope TA, Raleigh DR, Wilson DM, Evans MJ, VanBrocklin HF, Ozawa T, Flavell RR. PMID: 31381351.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    11. Divergent synthesis of organophosphate [11C]VX- and [11C]Sarin-surrogates from a common set of starting materials. Appl Radiat Isot. 2019 Sep; 151:182-186. Hayes TR, Blecha JE, Thompson CM, Gerdes JM, VanBrocklin HF. PMID: 31202183.
      View in: PubMed   Mentions:    Fields:    
    12. Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-PD-1 Therapy. Cancer Res. 2019 07 01; 79(13):3455-3465. Levi J, Lam T, Goth SR, Yaghoubi S, Bates J, Ren G, Jivan S, Huynh TL, Blecha JE, Khattri R, Schmidt KF, Jennings D, VanBrocklin H. PMID: 31064845.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    13. Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer. J Nucl Med. 2019 07; 60(7):910-916. Behr SC, Aggarwal R, VanBrocklin HF, Flavell RR, Gao K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, Carroll PR, Nguyen HG, Greene KL, Langton-Webster B, Berkman CE, Seo Y. PMID: 30464040.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    14. Radiosynthesis of O-(1-[18 F]fluoropropan-2-yl)-O-(4-nitrophenyl)methylphosphonate: A novel PET tracer surrogate of sarin. J Labelled Comp Radiopharm. 2018 12; 61(14):1089-1094. Hayes TR, Thompson CM, Blecha JE, Gerdes JM, VanBrocklin HF. PMID: 30347484.
      View in: PubMed   Mentions: 2     Fields:    
    15. A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors. . 2018 12; 17(12):2702-2709. Chamberlain CE, German MS, Yang K, Wang J, VanBrocklin H, Regan M, Shokat KM, Ducker GS, Kim GE, Hann B, Donner DB, Warren RS, Venook AP, Bergsland EK, Lee D, Wang Y, Nakakura EK. PMID: 30254185.
      View in: PubMed   Mentions:
    16. Radiosynthesis, ex Vivo Biodistribution, and in Vivo Positron Emission Tomography Imaging Evaluations of [11C]2-Pyridinealdoxime Methiodide ([11C]2-PAM): A First-In-Class Antidote Tracer for Organophosphate Intoxication. ACS Chem Neurosci. 2018 12 19; 9(12):3007-3014. Neumann KD, Blecha JE, Hayes TR, Huynh T, Chao CK, Guilloteau N, Zinn KR, VanBrocklin HF, Thompson CM, Gerdes JM. PMID: 30071719.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    17. Late-stage deuteration of 13C-enriched substrates for T1 prolongation in hyperpolarized 13C MRI. Chem Commun (Camb). 2018 May 17; 54(41):5233-5236. Taglang C, Korenchan DE, von Morze C, Yu J, Najac C, Wang S, Blecha JE, Subramaniam S, Bok R, VanBrocklin HF, Vigneron DB, Ronen SM, Sriram R, Kurhanewicz J, Wilson DM, Flavell RR. PMID: 29726563.
      View in: PubMed   Mentions: 4     Fields:    
    18. Quantification of 89 Zr-Iron oxide nanoparticle biodistribution using PET-MR and ultrashort TE sequences. J Magn Reson Imaging. 2018 12; 48(6):1717-1720. Jordan CD, Han M, Kondapavulur S, Vera DB, Neumann KD, Moore T, Stillson C, Krug R, Behr S, Seo Y, VanBrocklin HF, Larson PEZ, Wilson M, Martin AJ, Hetts SW. PMID: 29761624.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    19. [11C]Para-Aminobenzoic Acid: A Positron Emission Tomography Tracer Targeting Bacteria-Specific Metabolism. ACS Infect Dis. 2018 07 13; 4(7):1067-1072. Mutch CA, Ordonez AA, Qin H, Parker M, Bambarger LE, Villanueva-Meyer JE, Blecha J, Carroll V, Taglang C, Flavell R, Sriram R, VanBrocklin H, Rosenberg O, Ohliger MA, Jain SK, Neumann KD, Wilson DM. PMID: 29712422.
      View in: PubMed   Mentions: 9     Fields:    Translation:Cells
    20. Imaging Active Infection in vivo Using D-Amino Acid Derived PET Radiotracers. Sci Rep. 2017 08 11; 7(1):7903. Neumann KD, Villanueva-Meyer JE, Mutch CA, Flavell RR, Blecha JE, Kwak T, Sriram R, VanBrocklin HF, Rosenberg OS, Ohliger MA, Wilson DM. PMID: 28801560.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    21. A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant. Cancer Res. 2017 06 01; 77(11):2893-2902. PMID: 28572504.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    22. An improved radiosynthesis of O-(2-[18 F]fluoroethyl)-O-(p-nitrophenyl)methylphosphonate: A first-in-class cholinesterase PET tracer. J Labelled Comp Radiopharm. 2017 06 15; 60(7):337-342. PMID: 28406525.
      View in: PubMed   Mentions: 2     Fields:    
    23. An updated synthesis of [11 C]carfentanil for positron emission tomography (PET) imaging of the µ-opioid receptor. J Labelled Comp Radiopharm. 2017 06 30; 60(8):375-380. PMID: 28419528.
      View in: PubMed   Mentions: 3     Fields:    
    24. In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory Arthritis. Mol Imaging. 2017 01 01; 16:1536012117712638. PMID: 28625080.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    25. Optimization of an endovascular magnetic filter for maximized capture of magnetic nanoparticles. Biomed Microdevices. 2016 12; 18(6):109. PMID: 27830455.
      View in: PubMed   Mentions: 2     Fields:    Translation:Cells
    26. Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer. J Med Chem. 2016 06 23; 59(12):5684-94. PMID: 27228467.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    27. Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine. Brain. 2016 07; 139(Pt 7):1994-2001. PMID: 27234268.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    28. Site-Specific Radiofluorination of Biomolecules with 8-[(18)F]-Fluorooctanoic Acid Catalyzed by Lipoic Acid Ligase. ACS Chem Biol. 2016 06 17; 11(6):1587-94. PMID: 27008570.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    29. Caged [(18)F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography. Bioconjug Chem. 2016 Jan 20; 27(1):170-8. PMID: 26649808.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    30. Non-invasive imaging and cellular tracking of pulmonary emboli by near-infrared fluorescence and positron-emission tomography. Nat Commun. 2015 Oct 01; 6:8448. PMID: 26423607.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    31. Simultaneous (68)Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor. Abdom Imaging. 2015 Aug; 40(6):1432-40. PMID: 25820755.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    32. A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer. Nucl Med Biol. 2015 Oct; 42(10):780-7. PMID: 26169882.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    33. Somatostatin imaging of neuroendocrine-differentiated prostate cancer. Clin Nucl Med. 2015 Jun; 40(6):540-1. PMID: 25783510.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    34. Synthesis and evaluation of constrained phosphoramidate inhibitors of prostate-specific membrane antigen. Bioorg Med Chem Lett. 2015 Jun 15; 25(12):2536-9. PMID: 25956413.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    35. Imaging active urokinase plasminogen activator in prostate cancer. Cancer Res. 2015 Apr 01; 75(7):1225-35. PMID: 25672980.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    36. A boronate-caged [¹8F]FLT probe for hydrogen peroxide detection using positron emission tomography. J Am Chem Soc. 2014 Oct 22; 136(42):14742-5. PMID: 25310369.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    37. A novel fluorine-18 ß-fluoroethoxy organophosphate positron emission tomography imaging tracer targeted to central nervous system acetylcholinesterase. ACS Chem Neurosci. 2014 Jul 16; 5(7):519-24. PMID: 24716794.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    38. Imaging the urokinase plasminongen activator receptor in preclinical breast cancer models of acquired drug resistance. Theranostics. 2014; 4(3):267-79. PMID: 24505235.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    39. Hyperpolarized [1-13C]dehydroascorbate MR spectroscopy in a murine model of prostate cancer: comparison with 18F-FDG PET. J Nucl Med. 2013 Jun; 54(6):922-8. PMID: 23575993.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals
    40. Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer. Cancer Res. 2013 Apr 01; 73(7):2070-81. PMID: 23400595.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    41. Imaging a functional tumorigenic biomarker in the transformed epithelium. Proc Natl Acad Sci U S A. 2013 Jan 02; 110(1):93-8. PMID: 23248318.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    42. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model. Mol Imaging Biol. 2012 Dec; 14(6):735-42. PMID: 22382618.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    43. Novel human single chain antibody fragments that are rapidly internalizing effectively target epithelioid and sarcomatoid mesotheliomas. Cancer Res. 2011 Apr 01; 71(7):2428-32. Iyer AK, Lan X, Zhu X, Su Y, Feng J, Zhang X, Gao D, Seo Y, Vanbrocklin HF, Broaddus VC, Liu B, He J. PMID: 21447742.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    44. Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems. Clin Cancer Res. 2011 Apr 15; 17(8):2339-49. More SS, Itsara M, Yang X, Geier EG, Tadano MK, Seo Y, Vanbrocklin HF, Weiss WA, Mueller S, Haas-Kogan DA, Dubois SG, Matthay KK, Giacomini KM. PMID: 21421857.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    45. The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma. Biomaterials. 2011 Apr; 32(10):2605-13. Iyer AK, Su Y, Feng J, Lan X, Zhu X, Liu Y, Gao D, Seo Y, Vanbrocklin HF, Courtney Broaddus V, Liu B, He J. PMID: 21255833.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    46. Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET. Med Phys. 2010 Sep; 37(9):4861-7. Lee CL, Wahnishe H, Sayre GA, Cho HM, Kim HJ, Hernandez-Pampaloni M, Hawkins RA, Dannoon SF, VanBrocklin HF, Itsara M, Weiss WA, Yang X, Haas-Kogan DA, Matthay KK, Seo Y. PMID: 20964203.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    47. Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment. J Nucl Med. 2010 Mar; 51(3):427-32. He J, Wang Y, Feng J, Zhu X, Lan X, Iyer AK, Zhang N, Seo Y, VanBrocklin HF, Liu B. PMID: 20150269.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    48. Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer. J Nucl Med. 2009 Dec; 50(12):2042-8. Lapi SE, Wahnishe H, Pham D, Wu LY, Nedrow-Byers JR, Liu T, Vejdani K, VanBrocklin HF, Berkman CE, Jones EF. PMID: 19910433.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    49. Development of an optimized activatable MMP-14 targeted SPECT imaging probe. Bioorg Med Chem. 2009 Jan 15; 17(2):653-9. Watkins GA, Jones EF, Scott Shell M, VanBrocklin HF, Pan MH, Hanrahan SM, Feng JJ, He J, Sounni NE, Dill KA, Contag CH, Coussens LM, Franc BL. PMID: 19109023.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    50. Kinetic analysis of 18F-fluorodihydrorotenone as a deposited myocardial flow tracer: comparison to 201Tl. J Nucl Med. 2004 Nov; 45(11):1950-9. Marshall RC, Powers-Risius P, Reutter BW, O'Neil JP, La Belle M, Huesman RH, VanBrocklin HF. PMID: 15534068.
      View in: PubMed   Mentions: 20     Fields:    Translation:Animals
    Henry's Networks
    Concepts (247)
    Derived automatically from this person's publications.
    _
    Co-Authors (72)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _